[go: up one dir, main page]

AU2001261375A1 - Human caspase-12 materials and methods - Google Patents

Human caspase-12 materials and methods

Info

Publication number
AU2001261375A1
AU2001261375A1 AU2001261375A AU6137501A AU2001261375A1 AU 2001261375 A1 AU2001261375 A1 AU 2001261375A1 AU 2001261375 A AU2001261375 A AU 2001261375A AU 6137501 A AU6137501 A AU 6137501A AU 2001261375 A1 AU2001261375 A1 AU 2001261375A1
Authority
AU
Australia
Prior art keywords
materials
methods
human caspase
caspase
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261375A
Inventor
Rolf F. Kletzien
Ilene M. Reardon
Katherine L. Weiland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of AU2001261375A1 publication Critical patent/AU2001261375A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001261375A 2000-05-09 2001-05-08 Human caspase-12 materials and methods Abandoned AU2001261375A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20316200P 2000-05-09 2000-05-09
US60203162 2000-05-09
PCT/US2001/015103 WO2001085961A2 (en) 2000-05-09 2001-05-08 Human caspase-12

Publications (1)

Publication Number Publication Date
AU2001261375A1 true AU2001261375A1 (en) 2001-11-20

Family

ID=22752769

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261375A Abandoned AU2001261375A1 (en) 2000-05-09 2001-05-08 Human caspase-12 materials and methods

Country Status (3)

Country Link
US (1) US6833248B2 (en)
AU (1) AU2001261375A1 (en)
WO (1) WO2001085961A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030068655A1 (en) * 2001-09-12 2003-04-10 Protiveris, Inc. Microcantilever apparatus and methods for detection of enzymes
US7134459B2 (en) * 2003-06-12 2006-11-14 Symyx Technologies, Inc. Methods and apparatus for mixing powdered samples
US20060024699A1 (en) * 2004-06-23 2006-02-02 Junichi Hitomi Method for evaluating a substance capable of effecting on endoplasmic reticulum stress-and/or amyloid beta-induced apoptosis
US8507434B2 (en) 2007-01-03 2013-08-13 The Johns Hopkins University Peptide modulators of angiogenesis and use thereof
EP2042232A1 (en) * 2007-07-25 2009-04-01 Symyx Technologies, Inc. Systems and methods for mixing materials
US20110152343A1 (en) * 2009-12-22 2011-06-23 Functional Genetics, Inc. Protease inhibitors and broad-spectrum antiviral
CA2940513C (en) 2013-03-11 2023-08-15 University Of Florida Research Foundation, Inc. Delivery of card protein as therapy for ocular inflammation
EP3107939B1 (en) 2014-02-19 2020-06-17 University of Florida Research Foundation, Inc. Delivery of nrf2 as therapy for protection against reactive oxygen species
EP4050020A1 (en) 2014-03-11 2022-08-31 University of Florida Research Foundation, Inc. Aav-expressed m013 protein as an anti-inflammatroy therapeutic for use in a method of treating inflammatory ocular disease
US20170146517A1 (en) 2015-11-20 2017-05-25 Oregon Health And Science University Compounds and methods used in assessing mono-parp activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU751167B2 (en) * 1998-04-16 2002-08-08 General Hospital Corporation, The Programmed cell death and caspase-12
CA2416691A1 (en) * 2000-07-21 2002-01-31 Incyte Genomics, Inc. Proteases

Also Published As

Publication number Publication date
WO2001085961A3 (en) 2002-05-23
US6833248B2 (en) 2004-12-21
US20030165488A1 (en) 2003-09-04
WO2001085961A2 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2001285020A1 (en) P97-active agent conjugates and their methods of use
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002314466A1 (en) Withasol and methods of use
AU2001264258A1 (en) Nonwoven-fabric laminate and use thereof
AU715620C (en) Therapeutic methods and uses
AU2002211717A1 (en) Stresscopins and their uses
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2002211183A1 (en) Prosthetic construct and methods for its manufacture and use
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU7458201A (en) Laminate and use thereof
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001249692A1 (en) Phospholipid scramblases and methods of use thereof
AU4432001A (en) Trityl-type compounds and their use
AU2001274309A1 (en) Phosphoglycan messengers and their medical uses
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2002256556A1 (en) Sea-trosy and related methods
AU2669201A (en) Taccalonolides and their use
AU2001235364A1 (en) Tetrahydronaphtalene derivatives and their use